JP2024532957A5 - - Google Patents
Info
- Publication number
- JP2024532957A5 JP2024532957A5 JP2024533929A JP2024533929A JP2024532957A5 JP 2024532957 A5 JP2024532957 A5 JP 2024532957A5 JP 2024533929 A JP2024533929 A JP 2024533929A JP 2024533929 A JP2024533929 A JP 2024533929A JP 2024532957 A5 JP2024532957 A5 JP 2024532957A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- liver
- fibrosis
- elf
- score
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163233133P | 2021-08-13 | 2021-08-13 | |
| US63/233,133 | 2021-08-13 | ||
| PCT/US2022/040227 WO2023018972A1 (en) | 2021-08-13 | 2022-08-12 | Methods and compositions for treating fibrotic liver conditions, using udenafil compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024532957A JP2024532957A (ja) | 2024-09-10 |
| JP2024532957A5 true JP2024532957A5 (cg-RX-API-DMAC7.html) | 2025-08-19 |
Family
ID=83355014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024533929A Pending JP2024532957A (ja) | 2021-08-13 | 2022-08-12 | ウデナフィル組成物を用いた線維肝状態を処置する方法および組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20230218622A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4384176A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024532957A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022325803A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3229274A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024001972A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023018972A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12396708B2 (en) * | 2024-01-08 | 2025-08-26 | Echosens Sa | Method for determining an index for assessing a cardiac function of a subject |
| EP4582017A1 (en) * | 2024-01-08 | 2025-07-09 | Echosens | Method for determining an index for assessing a cardiac function of a subject |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0202254D0 (en) * | 2002-01-31 | 2002-03-20 | Pfizer Ltd | Prevention of scarring |
| EP1888074B1 (en) * | 2005-06-10 | 2011-12-21 | Dong-A Pharmaceutical Co., Ltd. | Agent for the prevention and treatment of liver diseases containing pyrazolopyrimidine derivative |
| MX390977B (es) | 2014-08-12 | 2025-03-21 | Mezzion Pharma Co Ltd | Metodos para mejorar el rendimiento miocardico en pacientes con cirugia de fontan que utilizan composiciones de udenafilo |
-
2022
- 2022-08-12 WO PCT/US2022/040227 patent/WO2023018972A1/en not_active Ceased
- 2022-08-12 JP JP2024533929A patent/JP2024532957A/ja active Pending
- 2022-08-12 EP EP22772634.6A patent/EP4384176A1/en active Pending
- 2022-08-12 AU AU2022325803A patent/AU2022325803A1/en active Pending
- 2022-08-12 CA CA3229274A patent/CA3229274A1/en active Pending
- 2022-08-12 US US17/887,091 patent/US20230218622A1/en active Pending
-
2024
- 2024-02-13 MX MX2024001972A patent/MX2024001972A/es unknown
-
2025
- 2025-01-18 US US19/031,865 patent/US20250186448A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Agabiti Rosei et al. | Evaluation of the efficacy and tolerability of nebivolol versus lisinopril in the treatment of essential arterial hypertension: a randomized, multicentre, double-blind study | |
| AU2017327383A1 (en) | Method of reducing thyroid-associated side effects | |
| JP2001199882A (ja) | 感冒・鼻炎用組成物 | |
| EP2988750B9 (en) | Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias | |
| JP2025515491A5 (cg-RX-API-DMAC7.html) | ||
| CN108619138B (zh) | 血管紧张素受体拮抗剂和脑啡肽酶抑制剂的复合物及其用途 | |
| JPH0575729B2 (cg-RX-API-DMAC7.html) | ||
| JP2025118624A (ja) | ウデナフィル組成物を用いた単心室心疾患における運動能力、単心室性能、および心筋性能指数(mpi)を改善する方法 | |
| KR100907938B1 (ko) | 발기 기능장애의 치료를 위한 알카노일 l-카르니틴의 용도 | |
| DE69812028T2 (de) | Creatine Derivate für Asthma | |
| WO2008057464A2 (en) | Compositions and methods for improving the bioavailability of liothyronine | |
| JP2022518527A (ja) | パーキンソン病の患者を治療する方法 | |
| JP7366108B2 (ja) | ロキソプロフェン又はその塩及びビタミンb12類を含有する経口用医薬組成物 | |
| JP2025505187A5 (cg-RX-API-DMAC7.html) | ||
| JPS60215635A (ja) | アザプロパゾンを含有する医薬品製剤 | |
| US10758517B2 (en) | mPGES-1 inhibitor for the treatment of osteoarthritis pain | |
| JP4702054B2 (ja) | 増強剤 | |
| KR20180038003A (ko) | 수축력 저하 수반성 배뇨근 과활동 개선제 | |
| JPH08253415A (ja) | 抗動脈硬化治療剤 | |
| WO2022004867A1 (ja) | 排尿症状治療剤 | |
| US20230270724A1 (en) | PDE3 inhibitors for treating viral infections | |
| CN111973579A (zh) | 丁酸盐在制备治疗或预防肾损伤的药物中的应用 | |
| JP5923044B2 (ja) | 活性成分としてl−カルニチンまたはプロピオニルl−カルニチンを含む慢性静脈不全の予防または治療のための併用組成物 | |
| HUP0201650A2 (hu) | Amino-tetralin-származékok alkalmazása szív- és érrendszeri betegségek gyógykezelésére használható gyógyszerek előállítására | |
| JP2025505632A5 (cg-RX-API-DMAC7.html) |